RecruitingPhase IIEN originalLung cancerMetastatic / advanced

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The purpose of this study is to evaluate the safety, efficacy and pharmacokinetics (PK) of zipalertinib in participants with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) harboring EGFR ex20ins mutations and other mutations.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek co najmniej 18 lat
  • •Potwierdzony zaawansowany rak płuca niedrobnokomórkowy z mutacją EGFR ex20ins
  • •Zgoda pacjenta na uczestnictwo w badaniu (Grupa A i B)
  • •Grupa A: Choroba postępiła pomimo wcześniejszego leczenia innymi lekami na tę mutację (np. amivantamab, sunvozertinib, BLU451)
  • •Grupa B: Pacjent nie otrzymywał jeszcze leczenia zaawansowanego raka i nie jest kandydatem do standardowej chemioterapii
  • •Jeśli są przerzuty do mózgu, muszą być stabilne i bez pogorszenia przez co najmniej 4 tygodnie

✗ Disqualifies

  • •Niekontrolowane napady padacze w historii choroby
  • •Rozległa choroba oponowo-móżdżkowa

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
October 6, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (80)

University of Alabama at Birmingham

Birmingham, United States

City of Hope - Duarte

Duarte, United States

Beth Israel Deaconess Medical Center

Boston, United States

Comprehensive Cancer Centers of Nevada - Central Valley - Twain

Las Vegas, United States

Memorial Sloan Kettering Cancer Center - Basking Ridge

Basking Ridge, United States

Memorial Sloan Kettering Cancer Center - Monmouth

Middletown, United States

Memorial Sloan Kettering Cancer Center - Bergen

Montvale, United States

Memorial Sloan Kettering Cancer Center - Commack

Commack, United States

Memorial Sloan Kettering Cancer Center - Westchester

Harrison, United States

MSK Cancer Center

Long Island City, United States

Memorial Sloan Kettering Cancer Center - Nassau

Uniondale, United States

Gabrail Cancer and Research Center

Canton, United States

Zangmeister Cancer Center

Columbus, United States

The Toledo Clinic Cancer Center

Toledo, United States

SCRI Oncology Partners

Nashville, United States

University of Texas MD Anderson Cancer Center

Houston, United States

Virginia Cancer Specialists

Fairfax, United States

IDS Pharmacy

Milwaukee, United States

Bankstown-Lidcombe Hospital

Bankstown, Australia

Genesis Care North Shore

Saint Leonards, Australia

Joondalup Hospital Pharmacy

Joondalup, Australia

William Osler Health System - Brampton Civic Hospital

Brampton, Canada

Nouvel Hôpital Civil

Strasbourg, France

Centre Leon Berard

Lyon, France

CHU Caen Normandie

Caen, France

Centre Hospitalier Universitaire Limoges

Limoges, France

Hopital Haut Leveque

Pessac, France

Hôpital Nord de Marseille

Marseille, France

Hopital Nord Laennec

Saint-Herblain, France

Hopital Ambroise Pare

Boulogne-Billancourt, France

Institut Curie

Paris, France

Gesundheit Nordhessen Holding AG

Kassel, Germany

Uniklinik Dresden

Dresden, Germany

UKGM Studienzentrale

Giessen, Germany

UKR Innere Med II Pneumologie

Regensburg, Germany

Queen Mary Hospital

Pok Fu Lam, Hong Kong

Azienda Ospedaliero - Universitaria Careggi

Florence, Italy

Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST

Meldola, Italy

Azienda Socio-Sanitaria Territoriale di Cremona

Cremona, Italy

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele

Milan, Italy

Azienda Ospedaliero-Universitaria di Parma

Parma, Italy

Ospedale S. Maria delle Croci

Ravenna, Italy

Aichi Cancer Center

Nagoya, Japan

National Cancer Center Hospital East

Kashiwa-shi, Japan

NHO Kyushu Cancer Center

Fukuoka, Japan

Sendai Kousei Hospital

Sendai, Japan

Niigata Cancer Center Hospital

Niigata, Japan

Kindai University Hospital

Sayama, Japan

Shizuoka Cancer Center

Sunto-gun, Japan

National Cancer Center Hospital

Chuo Ku, Japan

Cancer Institute Hospital of JFCR

Koto-ku, Japan

Okayama University Hospital

Okayama, Japan

National Cancer Center - Korea

Goyang-si, South Korea

Saint Vincent's Hospital

Suwon, South Korea

Ajou University Hospital

Suwon, South Korea

Gyeongsang National University Hospital

Jinju, South Korea

Inha University Hospital

Incheon, South Korea

Chonnam National University Hwasun Hospital

Hwasun-gun, South Korea

Seoul National University Hospital

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Korea University Guro Hospital

Seoul, South Korea

Seoul St. Mary's Hospital

Soeul, South Korea

Hospital Regional Universitario de Málaga - Hospital General

Málaga, Spain

UOMi Clinica Mi Tres Torres

Barcelona, Spain

Hospital Quirónsalud Barcelona

Barcelona, Spain

Hospital Clinic de Barcelona

Barcelona, Spain

Complejo Hospitalario de Jaen

Jaén, Spain

MD Anderson Cancer Center Madrid

Madrid, Spain

Hospital Universitario Fundación Jiménez Díaz

Madrid, Spain

Hospital Universitario 12 de Octubre

Madrid, Spain

Hospital La Paz

Madrid, Spain

Istinye Üniversite Hastanesi Liv Hospital Bahcesehir

Esenyurt, Turkey (Türkiye)

Medical Park Seyhan Hastanesi

Adana, Turkey (Türkiye)

Trakya Üniversitesi Saglik Arastirma ve Uygulama Merkezi

Edirne, Turkey (Türkiye)

Bagcilar Medipol Mega Universite Hastanesi

Istanbul, Turkey (Türkiye)

Prof. Dr. Suleyman Yalcin Sehir Hastanesi

Istanbul, Turkey (Türkiye)

The Royal Free Hospital NHS Foundation Trust

Barnet, United Kingdom

Royal Free London NHS Foundation Trust

London, United Kingdom

The Christie NHS Foundation Trust

Manchester, United Kingdom

Nottingham University Hospitals NHS Trust

Nottingham, United Kingdom

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/2/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.